CLS is committed to providing the media with timely and accurate information related to California’s life sciences ecosystem. CLS welcomes all media inquiries from news organizations and reporters. Members of the media interested in speaking with CLS opinion leaders on issues of public policy, life sciences innovation, or issues related to the life sciences ecosystem in California, please contact our communication department.
Media Contact: PR@califesciences.org
Sep 1, 2021
Now beginning its ninth year, the California Life Sciences FAST Advisory Program has extended its reach this fall serving five young companies from the Los Angeles/Orange County and San Diego regions.
Read More Sep 1, 2021
California Life Sciences’ members represent the world’s most promising entrepreneurial start-ups, research institutions, investors and the full spectrum of life sciences, therapeutics, medical device and diagnostic companies that are addressing..
Read More Aug 27, 2021
The coronavirus pandemic continues to have an impact on California Life Sciences event planning, in particular our annual Pantheon celebration. The need for social distancing has meant that bringing large groups of people together isn’t viable right now.
Read More Aug 27, 2021
The restoration of California’s Research and Development (R&D) tax credit and Net Operating Loss (NOL) deduction has been one of California Life Sciences’ (CLS) top priorities for 2021.
Read More Aug 25, 2021
California Life Sciences (CLS), has partnered with MedTech Color, a non-profit organization with a mission to advance the representation of persons of color in the medtech industry. Last spring, CLS..
Read More Aug 17, 2021
FAST / CARB-X / Emerging Innovators News Applied Molecular Transport, LLC. (FAST Spring 2014) (Nasdaq: AMTI), a clinical-stage biopharmaceutical company, today announced additional Phase 1b data for oral AMT-101 in..
Read More